TIL Archived Articles
Instil Bio (NASDAQ:TIL): A Promising Biopharmaceutical Play with Global Ambitions
Published on November 30, 2024
Instil Bio, Inc. (NASDAQ:TIL): Promising Pipeline and Collaboration Agreements, but Significant Challenges Ahead
Published on September 24, 2024